SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-032816
Filing Date
2020-07-21
Accepted
2020-07-20 18:37:36
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 flgt-s3.htm S-3 492983
2 EX-4.4 flgt-ex44_149.htm EX-4.4 523229
3 EX-4.5 flgt-ex45_6.htm EX-4.5 469675
4 EX-5.1 flgt-ex51_8.htm EX-5.1 48899
5 EX-23.1 flgt-ex231_9.htm EX-23.1 2918
6 GRAPHIC gpeo314yhj42000001.jpg GRAPHIC 2450
7 GRAPHIC gpeo314yhj42000002.jpg GRAPHIC 3145
8 GRAPHIC g2xq3eawto15000001.jpg GRAPHIC 2765
9 GRAPHIC g2xq3eawto15000002.jpg GRAPHIC 3772
  Complete submission text file 0001564590-20-032816.txt   1556118
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-239964 | Film No.: 201037231
SIC: 8071 Services-Medical Laboratories